建立22项鼻窦结局测试(SNOT-22)的效用值:基于与欧洲五维健康量表三水平版(EQ-5D-3L)的交叉映射
本研究在加拿大温哥华等待双侧内镜下鼻窦手术的慢性鼻窦炎(CRS)患者中,采集SNOT-22与EQ-5D-3L问卷数据,用普通最小二乘法建立3个模型将SNOT-22条目映射为EQ-5D-3L效用值。共232名参与者完成两份问卷,SNOT-22总分与EQ-5D-3L效用值呈负相关,3个模型调整R²为0.28至0.33,均方根误差为0.23至0.24,非参数自助法分析显示结果稳健。
要点
- SNOT-22总分与EQ-5D-3L效用值呈负相关。
- 3个映射模型调整R²为0.28至0.33,均方根误差为0.23至0.24。
- 非参数自助法分析显示结果稳健,模型可用于CRS比较效果研究。
核心结论
- 本研究成功建立将SNOT-22应答与效用值关联的映射模型,该模型可用于评估CRS各种干预措施的比较效果研究。
研究设计与样本
- 研究数据来自加拿大温哥华被诊断为CRS并等待双侧内镜下鼻窦手术的患者,参与者完成SNOT-22与EQ-5D-3L问卷。
- 采用普通最小二乘法建立3个模型,以SNOT-22条目为自变量估计EQ-5D-3L效用值。
主要发现
- 共232名参与者完成SNOT-22和EQ-5D-3L。
- SNOT-22总分与EQ-5D-3L效用值之间呈负相关。
- 3个模型的调整R²范围为0.28至0.33,均方根误差为0.23至0.24。
- 非参数自助法分析显示结果稳健。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic rhinosinusitis (CRS) is a common condition for which there are numerous medical and surgical treatments. The 22-item Sino-Nasal Outcome Test (SNOT-22) is a patient-reported outcome measure often used with patients diagnosed with CRS. However, there are no utility values associated with the SNOT-22, limiting its use in comparative effectiveness research. The purpose of this study was to establish utilities for the SNOT-22 by mapping responses to utility values associated with the EuroQol-5-dimensional questionnaire-3-level version (EQ-5D-3L). METHODS: This study used data collected from patients diagnosed with CRS awaiting bilateral endoscopic sinus surgery in Vancouver, Canada. Study participants completed both the SNOT-22 and the EQ-5D-3L. Ordinary least squares was used for 3 models that estimated the EQ-5D-3L utility values as a function of the SNOT-22 items. RESULTS: A total of 232 participants completed both the SNOT-22 and the EQ-5D-3L. As expected, there was a negative relationship between the SNOT-22 global scores and EQ-5D-3L utility values. Adjusted R2 for the 3 models ranged from 0.28 to 0.33, and root mean squared errors between 0.23 and 0.24. A nonparametric bootstrap analysis demonstrated robustness of the findings. CONCLUSION: This study successfully developed a mapping model to associate utility values with responses to the SNOT-22. This model could be used to conduct comparative effectiveness research in CRS to evaluate the various interventions available for treating this condition.
引用
- Crump RT, Lai E, Liu G, et al. Establishing utility values for the 22-item Sino-Nasal Outcome Test (SNOT-22) using a crosswalk to the EuroQol-five-dimensional questionnaire-three-level version (EQ-5D-3L). Int Forum Allergy Rhinol. 2017. PMID: 28182331. doi:10.1002/alr.21917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。